174 related articles for article (PubMed ID: 22544449)
1. Urinary chemokines and anti-inflammatory molecules in renal transplanted patients as potential biomarkers of graft function: a prospective study.
Pereira AB; Teixeira AL; Rezende NA; Pereira RM; Miranda DM; Oliveira EA; Teixeira MM; Simões E Silva AC
Int Urol Nephrol; 2012 Oct; 44(5):1539-48. PubMed ID: 22544449
[TBL] [Abstract][Full Text] [Related]
2. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
3. Six-Month Urinary CCL2 and CXCL10 Levels Predict Long-term Renal Allograft Outcome.
Hirt-Minkowski P; Rush DN; Gao A; Hopfer H; Wiebe C; Nickerson PW; Schaub S; Ho J
Transplantation; 2016 Sep; 100(9):1988-96. PubMed ID: 27548845
[TBL] [Abstract][Full Text] [Related]
4. The role of chemokines and their receptors in the rejection of pig islet tissue xenografts.
Solomon MF; Kuziel WA; Mann DA; Simeonovic CJ
Xenotransplantation; 2003 Mar; 10(2):164-77. PubMed ID: 12588649
[TBL] [Abstract][Full Text] [Related]
5. Assessment of chemokine serum levels in epithelial ovarian cancer patients.
Falcão-Júnior JO; Teixeira-Carvalho A; Cândido EB; Lages EL; Ferreira Freitas G G; Lamaita RM; Freire Bonfim LP; Borges Salera R; Traiman P P; da Silva-Filho AL
Tumori; 2013; 99(4):540-4. PubMed ID: 24326845
[TBL] [Abstract][Full Text] [Related]
6. Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.
Niewczas MA; Ficociello LH; Johnson AC; Walker W; Rosolowsky ET; Roshan B; Warram JH; Krolewski AS
Clin J Am Soc Nephrol; 2009 Jan; 4(1):62-70. PubMed ID: 19073786
[TBL] [Abstract][Full Text] [Related]
7. Expression of IL-8 during reperfusion of renal allografts is dependent on ischemic time.
Araki M; Fahmy N; Zhou L; Kumon H; Krishnamurthi V; Goldfarb D; Modlin C; Flechner S; Novick AC; Fairchild RL
Transplantation; 2006 Mar; 81(5):783-8. PubMed ID: 16534483
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
Rothenbacher D; Müller-Scholze S; Herder C; Koenig W; Kolb H
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):194-9. PubMed ID: 16239601
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of chemokines in acute myocardial infarction.
Kobusiak-Prokopowicz M; Orzeszko J; Mazur G; Mysiak A; Orda A; Mazurek W
Kardiol Pol; 2005 Apr; 62(4):301-14; discussion 315-6. PubMed ID: 15928736
[TBL] [Abstract][Full Text] [Related]
10. Chemokine profile in women with moderate to severe anxiety and depression during pregnancy.
Camacho-Arroyo I; Flores-Ramos M; Mancilla-Herrera I; Cruz FMC; Hernández-Ruiz J; Diaz GP; Labonne BF; Del Pilar Meza-Rodríguez M; Gelman PL
BMC Pregnancy Childbirth; 2021 Dec; 21(1):807. PubMed ID: 34863117
[TBL] [Abstract][Full Text] [Related]
11. Evidence for interactions between inflammatory markers and renin-angiotensin system molecules in the occurrence of albuminuria in children with sickle cell anemia.
Belisário AR; Vieira ÉLM; de Almeida JA; Mendes FG; Miranda AS; Rezende PV; Viana MB; Simões E Silva AC
Cytokine; 2020 Jan; 125():154800. PubMed ID: 31442679
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor and monocyte chemotactic peptide-1: potential biomarkers of urinary tract obstruction in children with hydronephrosis.
Madsen MG; Nørregaard R; Palmfeldt J; Olsen LH; Frøkiær J; Jørgensen TM
J Pediatr Urol; 2013 Dec; 9(6 Pt A):838-45. PubMed ID: 23228281
[TBL] [Abstract][Full Text] [Related]
13. Urinary levels of CCL2 and CXCL10 chemokines as potential biomarkers of ongoing pathological processes in kidney allograft: an association with BK virus nephropathy.
Gniewkiewicz MS; Czerwińska M; Gozdowska J; Czerwińska K; Sadowska A; Dęborska-Materkowska D; Perkowska-Ptasińska A; Kosieradzki M; Durlik M
Pol Arch Intern Med; 2019 Sep; 129(9):592-597. PubMed ID: 31389404
[TBL] [Abstract][Full Text] [Related]
14. CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment.
Bandinelli F; Del Rosso A; Gabrielli A; Giacomelli R; Bartoli F; Guiducci S; Matucci Cerinic M
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S44-9. PubMed ID: 22691208
[TBL] [Abstract][Full Text] [Related]
15. Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients.
Alam R; York J; Boyars M; Stafford S; Grant JA; Lee J; Forsythe P; Sim T; Ida N
Am J Respir Crit Care Med; 1996 Apr; 153(4 Pt 1):1398-404. PubMed ID: 8616572
[TBL] [Abstract][Full Text] [Related]
16. The source matters: no impact of the CCL2/MCP-1-1-2518G polymorphism of the donor on renal allograft outcome during the first year after transplantation.
Lehmann I; Fischereder M; Böhmig GA; Regele H; Exner M; Raith M; Weiss N; Segerer S
Transplant Proc; 2008 Dec; 40(10):3359-61. PubMed ID: 19100389
[TBL] [Abstract][Full Text] [Related]
17. The contribution of chemokines and chemokine receptors to the rejection of fetal proislet allografts.
Solomon MF; Kuziel WA; Simeonovic CJ
Cell Transplant; 2004; 13(5):503-14. PubMed ID: 15565863
[TBL] [Abstract][Full Text] [Related]
18. Glomerular expression of C-C chemokines in different types of human crescentic glomerulonephritis.
Liu ZH; Chen SF; Zhou H; Chen HP; Li LS
Nephrol Dial Transplant; 2003 Aug; 18(8):1526-34. PubMed ID: 12897090
[TBL] [Abstract][Full Text] [Related]
19. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.
Taylor PC; Peters AM; Paleolog E; Chapman PT; Elliott MJ; McCloskey R; Feldmann M; Maini RN
Arthritis Rheum; 2000 Jan; 43(1):38-47. PubMed ID: 10643698
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases.
Silva TA; Garlet GP; Lara VS; Martins W; Silva JS; Cunha FQ
Oral Microbiol Immunol; 2005 Oct; 20(5):310-6. PubMed ID: 16101967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
